{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:59:26Z","timestamp":1793257166411,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.seminhematol.2015.01.006","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T11:02:57Z","timestamp":1421492577000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["The Histological Classification of Diffuse Large B-cell Lymphomas"],"prefix":"10.1053","volume":"52","author":[{"given":"Yi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2015.01.006_bib1","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib2","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib3","first-page":"2291","article-title":"Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor","volume":"89","author":"Engelhard","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib4","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1182\/blood-2010-03-276766","article-title":"Immunoblastic morphology but not the immunohistochemical GCB\/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL","volume":"116","author":"Ott","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib7","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib8","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib9","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib10","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MOH.0b013e32834706ee","article-title":"Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma","volume":"18","author":"Sweetenham","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib12","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib13","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2010-03-272567","article-title":"MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-\u03baB-dependent lymphoma","volume":"116","author":"Milhollen","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib15","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Choi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"26","author":"Visco","year":"2012","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"29","author":"Meyer","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib18","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","article-title":"Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"117","author":"Gutierrez-Garcia","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/10428190500051844","article-title":"Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma","volume":"46","author":"Zu","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jcp.2008.057257","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)","volume":"62","author":"de Jong","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/his.12223","article-title":"Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients","volume":"63","author":"Culpin","year":"2013","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib22","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib23","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL-2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib25","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL-2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"suppl 4","key":"10.1053\/j.seminhematol.2015.01.006_bib26","first-page":"106","article-title":"MYC + aggressive-B-cell lymphomas: novel therapy of untreated Burkitt lymphoma (BL) and MYC + diffuse large B-cell lymphoma (DLBCL) with DA-EPOCH-R [abstract]","volume":"22","author":"Dunleavy","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib27","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1182\/blood-2007-10-119099","article-title":"Pathway analysis of primary central nervous system lymphoma","volume":"111","author":"Tun","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2010-07-297861","article-title":"Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma","volume":"117","author":"Sung","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib29","first-page":"266","article-title":"Differential gene expression in central nervous system lymphoma. Blood","volume":"113","author":"Rubenstein","year":"2009"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib30","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.3800691","article-title":"Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases","volume":"19","author":"Al-Abbadi","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.2399","article-title":"Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways","volume":"216","author":"Booman","year":"2008","journal-title":"J Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib32","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib33","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib34","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2003-08-2726","article-title":"Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas","volume":"103","author":"Grange","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib35","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","article-title":"Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting","volume":"25","author":"Ponzoni","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":"WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects","volume":"32","author":"Burg","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2559.2002.01291.x","article-title":"T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features","volume":"40","author":"Achten","year":"2002","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib39","first-page":"1269","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity","volume":"20","author":"Achten","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3324\/haematol.2009.009647","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response","volume":"95","author":"Van Loo","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib41","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3324\/haematol.2009.016931","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma","volume":"95","author":"Pittaluga","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib42","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/00000478-200211000-00008","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells","volume":"26","author":"Lim","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1634\/theoncologist.11-4-384","article-title":"T-cell\/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management","volume":"11","author":"Abramson","year":"2006","journal-title":"Oncologist"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib44","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.clml.2011.07.003","article-title":"EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals","volume":"11","author":"Beltran","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ajcp\/93.5.698","article-title":"Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations","volume":"93","author":"Abbondanzo","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib47","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin\u05f3s disease and lymphoproliferations resembling Hodgkin\u05f3s disease in patients receiving long-term low-dose methotrexate therapy","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib48","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pap.0000194627.50878.02","article-title":"Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation","volume":"12","author":"Aozasa","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/modpathol.2009.168","article-title":"Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios","volume":"23","author":"Loong","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib52","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1200\/JCO.2002.09.021","article-title":"Pyothorax-associated lymphoma: a review of 106 cases","volume":"20","author":"Nakatsuka","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/annonc\/mdl349","article-title":"Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients","volume":"18","author":"Narimatsu","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(02)00714-3","article-title":"Mediastinal (thymic) large B-cell lymphoma: where do we stand?","volume":"3","author":"Barth","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib55","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib56","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":"NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib57","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":"Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children","volume":"96","author":"Oschlies","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib58","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib59","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","article-title":"Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma","volume":"31","author":"Rodig","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib61","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u05f3s lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib62","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":"A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib63","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.leu.2403921","article-title":"ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas","volume":"19","author":"Gesk","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib64","doi-asserted-by":"crossref","first-page":"529572","DOI":"10.1155\/2012\/529572","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma","volume":"2012","author":"Morgan","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib65","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1200\/JCO.2008.21.5020","article-title":"Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis","volume":"27","author":"Laurent","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib66","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib67","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib68","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib69","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib70","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib71","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib72","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<288::AID-PATH419>3.0.CO;2-F","article-title":"Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient","volume":"189","author":"Cobo","year":"1999","journal-title":"J Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib73","first-page":"1637","article-title":"Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman\u05f3s disease and primary effusion lymphoma","volume":"78","author":"Teruya-Feldstein","year":"1998","journal-title":"Lab Invest"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib74","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib75","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/00000478-199908000-00023","article-title":"A biophenotypic human herpesvirus 8--associated primary bowel lymphoma","volume":"23","author":"Beaty","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib76","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00000478-200206000-00005","article-title":"Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype","volume":"26","author":"Petitjean","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib77","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4161\/cbt.10.10.13291","article-title":"Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice","volume":"10","author":"Ahmad","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib78","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/sj.onc.1210299","article-title":"Deregulation of c-Myc in primary effusion lymphoma by Kaposi\u05f3s sarcoma herpesvirus latency-associated nuclear antigen","volume":"26","author":"Bubman","year":"2007","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib79","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib80","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt\u05f3s lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib81","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt\u05f3s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib82","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":"Clinicopathological features of lymphoma\/leukemia patients carrying both BCL-2 and MYC translocations","volume":"94","author":"Tomita","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib83","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL-2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib84","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification","volume":"2011","author":"Jaffe","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib85","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib86","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1996.14.3.955","article-title":"Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients","volume":"14","author":"Zinzani","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib87","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin\u05f3s lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib88","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000478-200103000-00003","article-title":"Pathologic and clinical features of 77 Hodgkin\u05f3s lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study","volume":"25","author":"Cazals-Hatem","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib89","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.01.006_bib90","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11899-012-0130-5","article-title":"Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?","volume":"7","author":"Dunleavy","year":"2012","journal-title":"Curr Hematol Malig Rep"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196315000074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196315000074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:24:45Z","timestamp":1758522285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196315000074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0037196315000074"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.01.006","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Histological Classification of Diffuse Large B-cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}